• Updated: Feb. 12, 2021 7:07 p.m.
arrow Nurse at Montefiore New Rochelle Hospital goes on strike over safe staffing issues during the coronavirus pandemic, in New Rochelle. Mark Lennihan/AP/Shutterstock
When the first wave of COVID-19 hit Brooklyn Hospital Center, April Kehoe often found herself rushing between six different patients in a makeshift Intensive Care Unit far more than the one- or two- patient caseload typically considered safe for nurses in this setting.
The second surge has brought fewer hospitalizations, but Kehoe says the staffing shortages remain. She is still routinely assigned three or four intensive care patients at a time, a situation she says increases the risk of making medication errors or missing changes in a patient’s status.
Anchin’s Olamide Ajibesin Named to 2021 Top 25 Most Influential Women in Mid-Market M&A
Related Stories
March 4, 2021
February 26, 2021
December 31, 2020
Anchin’s Olamide Ajibesin.
How are you a champion for inclusion and equality?
As a Black leader, I am keenly aware of how many people look up to me within and outside the firm. I’m passionate about mentoring various minority groups and hope to spread the message of how young professionals can manifest their ambitions through self-advocacy, resilience and networking. I help promote senior level diverse talent in the financial services industry as a board member of the
NYC based Equity Alliance. One of the hottest topics in the last year is health and wellness, and I’m a member of the board of trustees at one of Brooklyn’s oldest hospitals, the
A new variant of the coronavirus has emerged in the United States, posing yet another public health challenge in a country already losing more than 3000 people to COVID-19 every day.
The mutated version of the virus, first identified in South Africa, was found in two cases in South Carolina.
Public health officials said itâs almost certain that there are more infections that have not been identified yet.
READ MORE:
Two cases of the South African strain of coronavirus has been found in the US.(AP)
They are also concerned that this version spreads more easily and that vaccines could be less effective against it.
Dr. Mark McClellan, a board member with Johnson & Johnson, says the New Jersey-based firm is going all out to have vaccine available so that 100 million Americans will get the shot by April.